PGI8: Rapid Impact of Rabeprazole on Symptom Distress Among Patients with Gastroesophageal Reflux Disease (English)
- New search for: Damiano, A.
- New search for: Adler, E.
- New search for: Siddique, R.
- New search for: Sloan, S.
- New search for: Bhattacharjya, A.
- New search for: Damiano, A.
- New search for: Adler, E.
- New search for: Siddique, R.
- New search for: Sloan, S.
- New search for: Bhattacharjya, A.
In:
VALUE IN HEALTH
;
4
, 2
;
124
;
2001
-
ISSN:
- Article (Journal) / Print
-
Title:PGI8: Rapid Impact of Rabeprazole on Symptom Distress Among Patients with Gastroesophageal Reflux Disease
-
Contributors:Damiano, A. ( author ) / Adler, E. ( author ) / Siddique, R. ( author ) / Sloan, S. ( author ) / Bhattacharjya, A. ( author )
-
Published in:VALUE IN HEALTH ; 4, 2 ; 124
-
Publisher:
- New search for: VALUE IN HEALTH
-
Publication date:2001-01-01
-
Size:124 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 4, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 47
-
EM2: The Impact of Hospital Costing Methods on Statistical Power in Multinational Clinical TrialsReed, S. D. / Friedman, J. Y. / Malenbaum, J. H. / Gnanasakthy, A. / Schulman, K. A. et al. | 2001
- 47
-
EM1: Risk Attitude: Association With Magnitude Of Risk and Patient CharacteristicsSinger, M. E. / Beaird, H. / Miller, L. A. N. et al. | 2001
- 48
-
EM3: Response Bias Among Likely Clinical Trial ParticipantsMcDonnell, D. D. / Donohue, J. A. et al. | 2001
- 48
-
MD1: Cost-Effectiveness of Airline Defibrillators: Is Peace of Mind More Important Than Saving Lives?Cram, P. / Vijan, S. / Wolbrink, A. M. / Fendrick, A. M. et al. | 2001
- 48
-
EM4: Can Unit Costs Be Compared Across Western European Countries?Brown, R. / Hutton, J. / Nuijten, M. et al. | 2001
- 49
-
MD4: Inclusion of Indirect Cost in Economic Outcomes Analyses of Medical Devices: How Important Is It?Subramanian, S. / Justason, B. J. et al. | 2001
- 49
-
MD2: Analysis of The Impact of Assistive Living Devices on Self-Assessed Health Status RatingRodney, A. B. / Xiao, H. / Robertson, T. et al. | 2001
- 49
-
MD3: The Diagnostic Accuracy of 18FDG-PET In Patients With Recurrent Papillary or Follicular Thyroid Cancer: A Systematic ReviewHooft, L. / Hoekstra, O. S. et al. | 2001
- 50
-
QL2: Logical Consistency and the Valuation of Health: An Analysis Of US Survey DataCraig, B. M. / Kind, P. et al. | 2001
- 50
-
QL1: Does Socioeconomic Status Affect The Valuation Of Health?Asada, Y. / Stout, N. K. / Kind, P. et al. | 2001
- 51
-
HP1: Ethnic Disparity of Combination Ribavirin/Interferon Alfa-2b Prescribing Among Hepatitis C-Infected Members in a Managed Care Organization (MCO)Phillips, A. L. / Schaffer, M. / Mansukani, S. et al. | 2001
- 51
-
QL4: Quality Of Life Messages in Prescription Drug Advertisements in Leading Medical Journals, 1990-99Zivin, K. / Neumann, P. et al. | 2001
- 51
-
QL3: Quality Of Life in Product Labeling: A Review of Marketed Drug ProductsChopra, T. / Shah, S. N. / McLaughlin-Miley, C. / Hinton, J. et al. | 2001
- 52
-
HP2: The Role Of Outlier Payments in Medicare Patients with Severe SepsisCooper, L. M. / Linde-Zwirble, W. T. et al. | 2001
- 52
-
HP3: Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: Evaluation of 30 Months of ExperienceAtherly, D. E. / Sullivan, S. D. / Fullerton, D. S. / Sturm, L. L. et al. | 2001
- 53
-
CN2: Effect of Including (Versus Excluding) Fates Worse Than Death on Utility MeasurementFranic, D. M. / Pathak, D. S. et al. | 2001
- 53
-
HP4: Assessing Lifestyle Drugs for Drug Benefit Formularies: A Cost-Utility Analysis Of Orlistat and Sibutramine for the Treatment of Obesity in AdultsTrakas, K. / Oh, P. / Leiter, L. / Shear, N. H. et al. | 2001
- 53
-
CN1: Utilities of Metastatic Breast Cancer Patients (PT) Treated With Taxanes Compared to Utilities of Oncology Nurses (NUR)Hauser, R. / Theriault, R. / Wilson, J. / Shepherd, M. / Lawson, K. / Koeller, J. et al. | 2001
- 54
-
CN3: Cost-Effectiveness Analysis of Irinotecan+5FU/FA Alone as First-Line Therapy in Advanced Colorectal Cancer in the UKBrown, R. / Sorensen, S. / Burrell, A. / Bearne, A. et al. | 2001
- 54
-
CN4: Economic Evaluation of Gemzar/Cisplatin Relative to Other Cisplatin Based Treatments for Non Small Cell Lung (NSCLC) Cancer In The UKBotwood, N. / McKendrick, J. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 55
-
CV2: Indirect Comparisons of Drugs Using Meta-Analysis: Validation of ResultsRoss, S. D. / Klawansky, S. / Allen, I. E. et al. | 2001
- 55
-
CV1: The Value of Compliance: Evidence From Two Patient CohortsMcGuigan, K. A. / Sokol, M. / Yao, J. / Haynes, J. / Qian, Q. / Boscarino, J. / Epstein, R. et al. | 2001
- 55
-
CV3: Do Short-Acting Opiates in Off-Pump Bypass Surgery Reduce Length of Stay or Total Hospital Costs?Reddy, P. / Feret, B. / Kulicki, L. / Jordan, S. / Donahue, S. / Quercia, R. et al. | 2001
- 56
-
CV5: The Cost-Effectiveness of Lifetime Factor VIII Prophylaxis in the Treatment of Severe Hemophilia ACharles, R. A. / Hay, J. et al. | 2001
- 56
-
CV4: Using UK Observational Data to Identify Possibilities for the Cost-Effective Improvement of the Treatment Of Atrial FibrillationPiercy, J. / James, P. / Baum, D. / Kuester, L. et al. | 2001
- 57
-
CV7: Cost-Effectiveness of Cardiovascular Disease (CVD) Prevention by Reducing Postprandial HyperglycemiaGlick, H. / Qiao, Q. / Grueger, J. et al. | 2001
- 57
-
CV8: Work-Related Outcomes of Patients Six Months After Myocardial InfarctionErickson, S. R. / McBurney, C. R. / Kline-Rogers, E. M. / Cooper, J. V. / Mani, O. C. M. / Eagle, K. A. et al. | 2001
- 57
-
CV6: Economic Evaluation of Dalteparin, Enoxaparin and Unfractionated Heparin in the Treatment of Deep Vein ThrombosisRisebrough, N. A. / Mittmann, N. et al. | 2001
- 58
-
DG2: The Incremental Cost of Diabetes in Chronic Illness Co-OccurrencesGaris, R. I. / Farmer, K. C. / Arora, M. et al. | 2001
- 58
-
DG1: The Relationship of Diabetes Symptoms and Health-Related Quality Of LifePfalzgraf, A. R. / Nau, D. P. et al. | 2001
- 59
-
ID1: Development of a Stochastic Decision Analysis Model of Treatment of Pyelonephritis from the Results of an RCTDavey, P. / Wang, J. / Claxton, K. / Fenwick, E. / Sculpher, M. / Talan, D. et al. | 2001
- 59
-
DG3: A Retrospective Evaluation of Nonsteroidal Anti-Inflammatory Drug-Induced Gastrointestinal Complications Among Adults in a Managed Care Health PlanDodd, M. A. / D Angio, R. / Gupchup, G. V. / Nelson, C. et al. | 2001
- 59
-
DG4: Disease Severity Determines Cost of Gastroesophageal Reflux Disease in a Midwest USA Health Care PlanBrelje, T. / Heaton, A. / Martin, S. / Bhattacharjya, A. / Dodd, S. / Thornhill, J. et al. | 2001
- 60
-
ID3: Cost-Effectiveness Analysis of An Intranasal Influenza Vaccine for Healthy ChildrenLuce, B. / Zangwill, K. / Palmer, C. / Mendelman, P. / Yan, L. / Wolff, M. / Cho, I. / Iacuzio, D. / Belshe, B. et al. | 2001
- 60
-
ID2: Health Values for the Lipodystrophy SyndromeLenert, L. A. / Fedderson, M. / Sturley, A. / Lee, D. et al. | 2001
- 61
-
MH1: The Impact of Second-Generation Antipsychotic Medications on Ambulatory Patients With SchizophreniaMulani, P. M. / McCombs, J. et al. | 2001
- 61
-
ID4: The Confusion Between Septicemia and Severe SepsisLinde-Zwirble, W. T. / Ball, D. E. / Cooper, L. M. / Lidicker, J. / Angus, D. C. et al. | 2001
- 61
-
MH2: Future Employability: A New Approach to Cost-Effectiveness Analysis of Antipsychotic TherapyGanguly, R. / Miller, L. S. / Martin, B. C. et al. | 2001
- 62
-
MH3: Clinical Assessment of Quality of Life Among Schizophrenia Patients With Deficit SyndromeRusso, P. / Kirkpatrick, B. et al. | 2001
- 62
-
MH4: Application of the Rasch Model to the SF36 Mental Health 5 Item Scale (MH5)Perneger, T. V. / Bovier, P. A. et al. | 2001
- 63
-
MS1: Cost-Effectiveness of Interventions For Lateral Epicondylitis: Results from a Randomized Controlled Trial in Primary CareKorthals-de Bos, I. B. C. / Smidt, N. / Tulder, M. / Bouter, L. et al. | 2001
- 63
-
MS2: Responsiveness to Change of the SF-36 in Rapolo, a Longitudinal Study of Rheumatoid Arthritis Patients Treated With EtanerceptLubeck, D. P. / Yelin, E. / Katz, P. / Roepke, L. / Wanke, L. A. / Buatti, M. et al. | 2001
- 63
-
MS3: Correlation of a Generic Health-Related Quality of Life Questionnaire and Self-Administered Rheumatoid Arthritis Disease Activity InstrumentKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 64
-
RS1: Outcome Assessment in Pediatric Asthma: A Comparison of Symptom-Free Time and Multi-Attribute ScaleChiou, C. F. / Weaver, M. R. / Bell, M. A. et al. | 2001
- 64
-
MS4: A Systematic Review of Health State Values for Osteoporosis Related ConditionsBrazier, J. E. / Green, C. / Kanis, J. et al. | 2001
- 65
-
RS2: Using Self-Administered Direct TTO Questions to Elicit Utility Values for Asthmatic Patients With Different Severity of DiseaseSzende, A. / Meszaros, A. / Berta, G. Y. / Stahl, E. / Svensson, K. et al. | 2001
- 65
-
RS4: A Model-Based Evaluation of Inhaled Steroids in Mild-To-Moderate AsthmaPaltiel, A. / Fuhlbrigge, A. / Kitch, B. / Weiss, S. / Neumann, P. / Kuntz, K. et al. | 2001
- 65
-
RS3: Psychometric Evaluation of the CAP-SYM Questionnaire: A New, Patient-Based Measure of Symptoms in Community Acquired PneumoniaLamping, D. / Schroter, S. / Sagnier, P. P. / Duprat-Lomon, I. et al. | 2001
- 66
-
PAM1: Joint Counts in Patients with New Onset Rheumatoid Arthritis: Patient vs. Physician AssessmentKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 66
-
PAM2: An Economic Evaluation of Osteoporosis Medication Use Patterns in a Managed Care Organization: A Time to Fracture AnalysisChen, K. S. / White, T. J. / Chang, E. et al. | 2001
- 67
-
PAM3: The Cost of Osteoporotic Fractures in the United KingdomBurge, R. T. / Worley, D. / Johansen, A. / Bose, U. et al. | 2001
- 67
-
PAM5: Investigating the Construct Validity of a Disease Specific and a General Quality of Life Instruments of Patients with Rheumatoid ArthritisLovas, K. / Szende, A. / Balint, G. / Szebenyi, B. / Hejj, G. et al. | 2001
- 67
-
PAM4: Use of COX 2 NSAIDS in Subjects Without Risk of Gastrointestinal Side EffectsHarley, C. R. et al. | 2001
- 68
-
PAM6: Cost-Effectiveness of Rofecoxib Versus NSAIDs in the Treatment of OsteoarthritisSullivan, P. / Hay, J. et al. | 2001
- 68
-
PAM8: Cost Comparison of Treating Osteoporosis Patients with Estrogens or Selective Estrogen Receptor Modulator in a Managed Care PopulationLiao, E. / Sweazy, L. / Huse, D. et al. | 2001
- 68
-
PAM7: The Correlation Between Arthritis Specific Measures and SF-36 Scales in Rheumatoid Arthritis PatientsLubeck, D. P. / Yelin, E. / Katz, P. / Roepke, L. / Wanke, L. A. / Buatti, M. et al. | 2001
- 69
-
PAM10: The Impact of Early Rheumatoid Arthritis on ProductivityKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 69
-
PAM9: Cost Comparison of Treating Rheumatoid Arthritis Patients with COX-2 Inhibitors or NSAIDs in a Managed Care PopulationLiao, E. / Kester, G. / Huse, D. et al. | 2001
- 70
-
PAM13: A Cost-Effectiveness Model Comparing Celecoxib and Rofecoxib to Traditional NSAIDs for Osteoarthritis TreatmentSchaefer, M. G. / Morreale, A. P. / Plowman, B. K. et al. | 2001
- 70
-
PAM12: Cost-Minimization Analysis of the Treatment of Rheumatoid Arthritis with Leflunomide in Comparison with the Combination of Infliximab and MethotrexateRubio-Terres, C. / Dominguez-Gil, A. et al. | 2001
- 70
-
PAM11: Applying Background Risk Distribution to Evaluate the Cost-Effectiveness of Three Preventive Drug Therapies for Osteoporotic FracturesGao, X. / Madhavan, S. / Nau, D. / Ambegaonkar, A. / Islam, S. / Rosenbluth, S. / Amonkar, M. et al. | 2001
- 71
-
PAM16: Cost Impact of COX-2 Inhibitors in a Managed Care Plan: Implications for Formulary Decision-MakingAtherly, D. E. / Fullerton, D. S. / Sturm, L. L. / Bryant, A. / Sullivan, S. D. et al. | 2001
- 71
-
PAM15: Evaluating Direct and Indirect Measures of Utility: Stability of the SF-6D in a Rheumatoid Arthritis PopulationCrawford, B. / Brazier, J. E. et al. | 2001
- 71
-
PAM14: Treatment with Leflunomide Improves the Utility of Patients with Active Rheumatoid Arthritis: An Application of the SF-6DCrawford, B. / Brazier, J. E. / Strand, V. / Doyle, J. et al. | 2001
- 72
-
PAM17: Important Issues in Number Needed to Treat Analysis in Osteoporosis TreatmentKemner, J. E. et al. | 2001
- 72
-
PAM18: Performance Assessment of Two Fatigue Instruments in an Early Rheumatoid Arthritis CohortDrabinski, A. / Kim, S. S. / Williams, G. / Formica, C. et al. | 2001
- 73
-
PAM20: Cost-Effectiveness of Acetylcisteine and Dimethylsulphoxide (DMSO) 50% for the Treatment of Patients with Reflex Sympathic Dystrophyvan Dieten, H. E. / Perez, R. S. / Tulder, M. W. / Boers, M. / Zuurmond, W. W. / de Lange, J. J. / Vondeling, H. et al. | 2001
- 73
-
PAM21: Manual Therapy is More Cost-Effective than Physical Therapy and GP Care for Patients with Neck PainKorthals-de Bos, I. B. / Hoving, J. / Tulder, M. / Bouter, L. et al. | 2001
- 73
-
PAM19: A Review of Functional Status Measures for Workers with Upper Extremity DisordersSalerno, D. F. / Copley-Merriman, C. / Taylor, T. N. / Shinogle, J. / Schulz, R. M. et al. | 2001
- 74
-
PAM23: Vertebral Fractures Among Glucocorticoid Patients Significantly Increase Medical Care CostsMeyer, J. W. / Burge, R. T. / Steinbuch, M. et al. | 2001
- 74
-
PAM22: Studying Predictors of Fractures Among Omnicare Nursing Home ResidentsOderda, G. M. / Gause, D. / Stuart, B. / Erwin, G. et al. | 2001
- 75
-
PAR2: Use of Respiratory Assist Devices by Medicare BeneficiariesSilverman, B. G. et al. | 2001
- 75
-
PAR3: The Standardized Asthma-Related Quality of Life Questionnaire (AQLQ-S): Does Socioeconomic Status Effect Measurements?Lynd, L. D. / Guh, D. / Pare, P. / Anis, A. et al. | 2001
- 75
-
PAR1: Cost of Asthma in Children in VladivostokProsekova, E. / Geltzer, B. / Dercach, V. / Bogdanovskiy, P. et al. | 2001
- 76
-
PAR5: Direct and Indirect Costs of Respiratory InfectionsBirnbaum, H. G. / Morley, M. A. / Greenberg, P. E. / Cifaldi, M. / Colice, G. L. et al. | 2001
- 76
-
PAR4: Comparison of Two Quality of Life Instruments in Patients with Chronic Obstructive Pulmonary DiseaseAubert, R. E. / Alemayehu, B. / Feifer, R. et al. | 2001
- 77
-
PAR6: Prophylactic Medication Utilization and Health Care Costs in Older Adults with Chronic Pulmonary AilmentsBalkrishnan, R. / Christensen, D. / Bowton, D. et al. | 2001
- 77
-
PAR8: A Cost-Effectiveness Analysis Comparing Levalbuterol and Albuterol in the Treatment of Moderate to Severe AsthmaCarter, C. T. / McGee, M. D. et al. | 2001
- 77
-
PAR7: Validation of a Model of Severity of Illness in Chronic Respiratory DiseaseSullivan, P. / Nichol, M. et al. | 2001
- 78
-
PAR9: Validation of a Rating Instrument Assessing the Inhalation Skills of Children with AsthmaPradel, F. G. / Weiss, S. / Tsoukleris, M. / Bollinger, M. B. / Fahlman, C. et al. | 2001
- 78
-
PAR10: Implementing Rasch Analysis in Psychometric Evaluation of Patient-Physician Interaction ScaleDalal, M. / Smith, E. / Lambert, B. / Olopade, C. / Crawford, S. et al. | 2001
- 78
-
PAR11: The Long-Term Societal Economic and Humanistic Benefits of Treating Acute Exacerbations of Chronic Bronchitis (AECB) with Gemifloxacin Versus ClarithromycinHalpern, M. / Kirsch, J. M. / Palmer, C. / Zodet, M. / Wilson, R. et al. | 2001
- 79
-
PAR12: Prospective Use of Web Based Technology to Evaluate Health Outcomes in a Large Cohort of Severe or Difficult to Treat AsthmaticsDolan, C. M. / Fisher, K. A. / Johnson, C. / Fraher, K. E. / Rothermich, E. A. / Fine, J. T. / Weiss, S. T. / Wenzel, S. et al. | 2001
- 79
-
PAR13: Hypothetical Versus Real Willingness to Pay in the Health Care Sector: Results from a Field ExperimentBlumenschein, K. / Johannesson, M. / Yokoyama, K. / Freeman, P. et al. | 2001
- 80
-
PAR15: Comparison of Health Care Resource Utilization of COPD Patients on Cilomilast, 15 mg BID Versus PlaceboBagchi, I. / Bakst, A. / Edelson, J. / Amit, O. et al. | 2001
- 80
-
PAR14: Assessment of the Relationship Between Disease Severity, Quality of Life and Willingness to Pay in AsthmaZillich, A. / Blumenschein, K. / Johannesson, M. / Freeman, P. et al. | 2001
- 80
-
PAR16: Cost of Treating Asthma in a Managed Care PopulationArmstrong, E. P. / Malone, D. C. / Rehfeld, R. A. et al. | 2001
- 81
-
PAR17: Patient Satisfaction with Non-Sedating AntihistaminesSahu, S. / Millard, R. et al. | 2001
- 81
-
PAR19: Impact of the Addition of Salmeterol to the Treatment of Asthma Patients in a Medicaid Fee-for-Service PopulationKlaurens, L. M. / Dodd, M. A. / Gupchup, G. V. / Kelly, H. W. / Hollarbush, J. et al. | 2001
- 81
-
PAR18: Costs of Treating COPD in Italy: A Burden of Illness StudyBonzanini, A. / Avossa, R. / Scipioni, E. / Gianfrate, F. et al. | 2001
- 82
-
PAR20: Effectiveness of Compliance on Health Care Resource Use in Asthma Patients Treated with Montelukast vs. Inhaled CorticosteroidsKutikova, L. / Bowman, L. / Morris, L. et al. | 2001
- 82
-
PAR21: Levalbuterol Use is Associated with Decreased Health Care Costs in Patients with More Severe AsthmaHuse, D. / McLoney, A. / Yeager, B. / Cerasoli, F. et al. | 2001
- 83
-
PAR23: Determinants of Inappropriate Antibiotic PrescribingWillis, M. K. et al. | 2001
- 83
-
PAR22: Impact of Levalbuterol Versus Racemic Albuterol on Outpatient Asthma Care ChargesHuse, D. / McLoney, A. / Yeager, B. / Cerasoli, F. et al. | 2001
- 84
-
PCN2: Which Variables Do Metastatic Breast Cancer Patients and Oncology Nurses Anchor on When Using the EuroQoL Descriptive System in Measuring Utilities with the Standard Gamble Technique?Hauser, R. / Koeller, J. et al. | 2001
- 84
-
PCN1: Categorization of Risk of Prostate Cancer: Pilot Test of Clinical Outcomes and Risk PerceptionsBruner, D. W. / Parlanti, A. A. / Ross, E. / Raysor, S. / Mazzoni, S. E. / Hanks, G. E. et al. | 2001
- 84
-
PCN3: Predictors of Chemotherapy-Related Neutropenia: A Review of the Clinical LiteraturePalmer, C. / Brown, R. / Wilson-Royalty, M. / Lawless, G. et al. | 2001
- 85
-
PCN5: Docetaxel/Doxorrubicin (DD) as First Line Chemotherapy: Quality of Life (QoL) in Patients (Pts) with Metastatic Breast Cancer (MBC)Bonicatto, S. C. et al. | 2001
- 85
-
PCN4: Comparing Mean Versus Median Survival as a Prelude to Cost-Effectiveness (C/E) AnalysesGagnon, D. D. / Martin, S. C. / van Hout, B. et al. | 2001
- 86
-
PCN7: Economic Evaluation of Gemzar and Best Supportive Care (BSC) Relative to Best Supportive Care Alone in the Treatment of Non Small Cell Lung (NSCLC) Cancer in the UKMcKendrick, J. / Botwood, N. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 86
-
PCN6: Can ICD-9 Codes Be Used as a Proxy for Disease Staging in Economic Evaluations?Thomas, S. K. / Brooks, S. E. / Mullins, C. D. et al. | 2001
- 86
-
PCN8: Economic Evaluation of Gemzar in the Treatment of Pancreatic Cancer in the UKStephenson, D. / Botwood, N. / McKendrick, J. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. et al. | 2001
- 87
-
PCN9: Economic Evaluation of Gemzar/Cisplatin Relative to Other New Agents for Non Small Cell Lung Cancer (NSCLC) in the UKLees, M. / Aristides, M. / Botwood, N. / McKendrick, J. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 87
-
PCN10: Cost-Effectiveness Model of Prostate-Specific Antigen (PSA) Screening for Prostate CancerSokolskiy, L. / Hay, J. W. et al. | 2001
- 88
-
PCN11: Economic Evaluation of Liposomal Doxorubicin vs Topotecan for Recurrent Ovarian Cancer in the UKSmith, D. H. / Drummond, M. F. / Johnston, S. / Gordon, A. et al. | 2001
- 88
-
PCN12: Cost-Utility Analysis Comparing Paclitaxel to Docetaxel in the Treatment of Metastatic Breast CancerHauser, R. / Theriault, R. / Shepherd, M. / Lawson, K. / Wilson, J. / Koeller, J. et al. | 2001
- 88
-
PCN13: Cost of Thrombocytopenia-Related Bleeding Among Patients with CancerElting, L. S. / Martin, C. G. / Hamblin, L. / Chau, Q. et al. | 2001
- 89
-
PCN15: Differences Between Preferences for Health States: The Chemotherapy Adverse Event Self-Assessed Response (CAESAR) QuestionnairePurdum, A. G. / Globe, D. / Mathes, A. / Nichol, M. B. et al. | 2001
- 89
-
PCN14: Choice of Localized Breast Cancer Treatments in a Medicare Population: A Comparison of Outcomes and CostsPolsky, D. / Venditti, L. / Mandelblatt, J. S. / Weeks, J. C. / Hadley, J. / Hwang, Y. T. / Schulman, K. et al. | 2001
- 90
-
PCN16: Chemotherapy Treatment in Newly Diagnosed Breast Cancer Patients in a Managed Care PopulationYazdani, C. / McLaughlin, T. / Koos, F. / Hansen, J. et al. | 2001
- 90
-
PCN17: An Analysis of Resource Use in the Treatment of Advanced Colorectal Cancer in the UKSorensen, S. / Brown, R. / De Cock, E. / Bearne, A. et al. | 2001
- 91
-
PCN20: Cost Minimization Analysis of Cefepime Versus Imipenem-Cilastatine in Cancer Patients with Short-Duration Febrile NeutropeniaVorobjov, P. / Fisenko, V. / Gerasimov, V. / Avxentieva, M. et al. | 2001
- 91
-
PCN19: Colorectal Cancer Screening Tests: Variation in Preferences Based on Gender and RaceStraus, W. / Schaffner, P. / Gold, K. / Pashos, C. / Mansley, E. et al. | 2001
- 91
-
PCN18: Colorectal Cancer Screening: Awareness, Utilization, and BarriersStraus, W. / Schaffner, P. / Gold, K. / Pashos, C. / Mansley, E. et al. | 2001
- 92
-
PCN22: Cost-Effectiveness Analysis Comparing Paclitaxel to Docetaxel in the Treatment of Metastatic Breast CancerHauser, R. / Koeller, J. et al. | 2001
- 92
-
PCN21: Health-Related Quality of Life After Androgen Deprivation Therapy in Men with Prostate CancerLubeck, D. P. / Grossfeld, G. D. / Carroll, P. R. et al. | 2001
- 93
-
PCN23: Disease Modeling: Developing the Infrastructure for a Comprehensive, Multi-National, Clinical and Economic Breast Cancer Treatment ModelBecker, R. V. / Noe, L. / Gore, M. / Martino, S. / Eiermann, W. / Namer, M. / Howell, A. / Bianco, A. / Watanabe, T. et al. | 2001
- 93
-
PCN24: Incidence and Cost of Hospitalization for 5-FU Toxicity Among Medicare Beneficiaries with Metastatic Colorectal CancerDelea, T. E. / Vera-Llonch, M. / Edelsberg, J. S. / McGarry, L. / Anton, S. / Ulcickas-Yood, M. / Oster, G. et al. | 2001
- 93
-
PCN25: A Quality of Life Audit of Patients with Non-Small Cell Lung Cancer Having Chemotherapy at One InstitutionMusgrave, K. R. / Wyld, D. / Abraham, R. et al. | 2001
- 94
-
PCN26: Systematic Assessment of Health-Related Quality of Life Instruments for Use in Clinical Trials of Non-Small Cell Lung CancerHuang, J. C. / Veenstra, D. L. et al. | 2001
- 94
-
PCN27: Cost of Treatment for Squamous Cell Carcinoma of the Head and Neck in the United StatesCronin, K. / Lee, B. / Wang, D. et al. | 2001
- 95
-
PCV1: A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin as Prevention of Ischemic Events in Patients with Established Peripheral Artery DiseaseDecerbo, M. C. / Baroletti, S. A. / Isopo, S. / Silva, M. / Talati, D. K. et al. | 2001
- 95
-
PCV2: Venous Thromboembolic (VTE) Complications Following Major Orthopedic Surgery: Frequency and Economic Consequences in HospitalGabriel, S. / Dinet, J. / Dispot, T. / Radal, C. et al. | 2001
- 95
-
PCN28: Detecting Recurrent Papillary or Follicular Thyroid Cancer in Clinical Practice: Need for a Change?Hooft, L. / Hoekstra, O. S. et al. | 2001
- 96
-
PCV4: Assessing Quality of Life in Patients Six Months After a Myocardial Infarction Using the SF-12McBurney, C. R. / Erickson, S. R. / Kline-Rogers, E. M. / Cooper, J. V. / Mani, O. C. / Eagle, K. A. et al. | 2001
- 96
-
PCV3: An Analysis of the Cost of Adverse Events Associated with the Use of HMG-CoA Reductase InhibitorsMcBurney, C. R. / Smith, D. et al. | 2001
- 97
-
PCV7: Cost-Utility Analysis of Drug Therapy Options for Intermittent ClaudicationMcGhan, W. F. et al. | 2001
- 97
-
PCV6: Estimating Incremental Costs for Additional Hospital DaysFriedman, J. Y. / Reed, S. D. / Gnanasakthy, A. / Schulman, K. A. et al. | 2001
- 97
-
PCV5: Cost of Treatment and Prevalence of Cardiovascular Disease Comorbidities and Risk Factors in the Severe and Persistently Mentally IllBellnier, T. J. / Labrum, A. / Karki, S. D. / Sundberg, J. et al. | 2001
- 98
-
PCV9: An Economic Analysis of Congestive Heart Failure (CHF) in the Louisiana Medicaid ProgramOgale, S. S. / Blake, S. G. / Biglane, G. C. / Medon, P. J. et al. | 2001
- 98
-
PCV10: Incidence of Rhabdomyolysis in Patients Initiated on HMG Co-A Reductase Inhibitor Therapy in a Managed Care OrganizationWhite, T. J. / Chang, E. Y. et al. | 2001
- 98
-
PCV8: Patient Compliance with Different Prescribed Regimens of Diltiazem in Angina Pectoris: Database Analysis in FranceBaptiste, C. / Guilhaume, C. et al. | 2001
- 99
-
PCV11: Cost of Warfarin Treatment of Atrial Fibrillation in Clinical PracticeAbdelhafiz, A. H. / Wheeldon, N. et al. | 2001
- 99
-
PCV12: Quality of Care in Older Patients Admitted to Hospital with Heart FailureAbdelhafiz, A. H. / Wheeldon, N. et al. | 2001
- 100
-
PCV13: Impact on Quality Adjusted Life Years on Enoxaparin for Preventing Thrombosis Among Hospitalized Medical PatientsRaisch, D. W. / Fye, C. L. / Sather, M. R. / Henderson, W. G. / Reda, D. J. / Sacks, J. M. / Lederle, F. L. et al. | 2001
- 100
-
PCV15: Economic Evaluation of Outpatient Anticoagulant/Antiplatelet Therapy Following Coronary Stenting in a Managed Care PopulationLiao, E. / Fronk, M. / Newell, J. / Huse, D. et al. | 2001
- 100
-
PCV14: Impact of Obesity on Health-Related Quality of Life (HRQoL): An Analysis of Behavioral Risk Factor Surveillance System (BRFSS) DataHassan, M. / Joshi, A. V. / Madhavan, S. / Amonkar, M. et al. | 2001
- 101
-
PCV16: Cost-Effectiveness Analysis of Enoxaparin Versus Unfractionated Heparin in Acute Coronary Syndrome Patients in PolandOrlewska, E. / Budaj, A. / Tereszkowski-Kaminski, D. et al. | 2001
- 101
-
PCV17: Quality of Life and Patient Preference as Predictors for Resource Utilization Among Patients with Heart Failure; Interim AnalysisShin, G. P. / Tooley, J. F. / Southworth, M. R. / Dunlap, S. / Boyer, J. G. / Johnson, N. E. et al. | 2001
- 102
-
PCV19: Discriminability for Risk of Cardiovascular EventsMilne, R. J. / Gamble, G. D. / Whitlock, G. / Irwin, R. J. / Jackson, R. T. et al. | 2001
- 102
-
PCV18: Framingham Risk Equations Predict Hospital Usage and MortalityMilne, R. J. / Gamble, G. D. / Whitlock, G. / Jackson, R. T. et al. | 2001
- 102
-
PCV20: Assessing the Total Cost of Management of a Patient with Deep Vein Thrombosis (DVT) in France and in ItalyLevy, E. / Gabriel, S. / Dinet, J. / Rudelli, G. et al. | 2001
- 103
-
PCV21: Cost-Effectiveness Analysis of Abciximab, Eptifibatide, and Tirofiban in Patients with Coronary SyndromesShahriar, J. / Shaw, J. W. / Malone, D. et al. | 2001
- 103
-
PCV22: In-Patient and Out-Patient Resource Utilization Among Patients with Acute Ischemic Stroke-The VA ExperienceL Italien, G. J. / Williams, L. S. / Weinberger, M. et al. | 2001
- 104
-
PCV24: Beyond the First Year: Patterns and Predictors of Long-Term Statin UtilizationBenner, J. S. / Federman, A. D. / Smitten, A. L. / Duty, S. / Glynn, R. J. / Avorn, J. et al. | 2001
- 104
-
PCV25: CHD Risk Factors and Therapy Duration of HMG-CoA Reductase Inhibitors (Statins) in a Medicaid PopulationNichol, M. B. / Bron, M. S. / Yu, W. et al. | 2001
- 104
-
PCV23: Pharmacoeconomic Evaluation of Usage of Unfractionated Heparin and Low Molecular Weight Heparin in the Treatment of Deep Vein Thrombosis in Long-Term Care ResidentsKarki, S. D. / Bellnier, T. J. / Karki, J. / Patterson, W. / Masood, R. et al. | 2001
- 105
-
PCV26: Caring for Hypertension on Initiation: Costs and Effectiveness (CHOICE). Design and Rationale of a Naturalistic StudyPayne, K. / Caro, J. / Hollenberg, N. / Jackson, J. / L Italien, G. / CHOICE Study Group et al. | 2001
- 105
-
PCV27: A Pharmacoeconomic Model to Evaluate Treatment Options for DVT PharmacoprophylaxisSpruill, W. J. / Wade, W. E. / Leslie, R. B. et al. | 2001
- 105
-
PCV28: Cholesterol Reduction Success Rates and Resource Utilization by GenderGraff, J. S. / Plante, M. / Smith, D. et al. | 2001
- 106
-
PCV30: Cost-Effectiveness Model of Thrombolytic Therapy for Acute Myocardial InfarctionMulani, P. / Hay, J. et al. | 2001
- 106
-
PCV29: Economic Outcomes of Patients Receiving Carvedilol Compared to Those Receiving No Beta-Blocker Therapy for the Treatment of Congestive Heart Failure in a Managed Care OrganizationWhite, T. J. / Chang, E. Y. / Leslie, R. S. / Jackson, A. J. et al. | 2001
- 107
-
PCV31: Closure of Atrial Septal Defect: Medico-Economic Arguments to Choose Between Invasive Surgery and Percutaneous Technique Using Septal OccluderLaroche, S. / Allenet, B. / Foroni, L. / Calop, J. et al. | 2001
- 107
-
PCV32: Strategies for Improving Compliance with HMG-CoA Reductase InhibitorsCoombs, J. H. / Cornish, L. / Hiller, P. / Smith, D. G. et al. | 2001
- 107
-
PCV33: Cost-Analysis of CABG Surgery in Patients with and without Rethoracotomy from the Hospital Perspective in GermanySpannheimer, A. / Mast, O. / Schlereth, T. / Thate-Waschke, I. M. / Dietrich, W. et al. | 2001
- 108
-
PCV35: Comparability of Published Studies on Cost-Effectiveness of Antihypertensive Therapy: Do the Results Help the Decision-Making Process?Mullins, C. D. / Akhras, K. S. / Blak, B. et al. | 2001
- 108
-
PCV34: Decision Analysis Model of Abciximab, Eptifibatide or Standard Therapy in Elective Stent Placement: A Canadian PerspectiveSridhar, K. / Gwadry, F. / Kidwai, B. / Almond, D. / Teefy, P. et al. | 2001
- 109
-
PCV36: Evaluation of Compliance and Persistence with HMG-CoA Reductase Inhibitors After a Myocardial Infarction Using Pharmacy Claims DataCoombs, J. H. / Cornish, L. / Hiller, P. / Smith, D. G. et al. | 2001
- 109
-
PCV37: The Cost-Effectiveness of Statins: Evidence from the ACCESS TrialSmith, D. G. et al. | 2001
- 110
-
PCV40: Cost-Effectiveness of Lipid Lowering Interventions in a Native American Cardiovascular Risk Reduction ProgramKumar, R. N. / Borrego, M. E. / Gupchup, G. V. / Anderson, J. R. / Burden, R. W. / Phillips, D. L. et al. | 2001
- 110
-
PCV39: Cost of Treatment of Hypercholesterolaemia to NHF Goals in AustraliaWlodarczyk, J. / Barter, P. j. / O Brien, R. / Talmont, D. / Ortiz, M. et al. | 2001
- 110
-
PCV38: Withdrawn| 2001
- 111
-
PCV41: Socioeconomic Relevance of Treatment of Chronic Heart Failure Stage NYHA II With Crataegus Extract WS 1442-One-Year Results of a Prospective Pharmacoeconomic StudyPfeil, T. / Rychlik, R. / Daniel, D. / Habs, M. / Klapper, H. G. / Bohm, M. et al. | 2001
- 111
-
PCV42: Patients' Willingness to Pay for Pharmacist Managed Warfarin Therapy at Community PharmaciesWong, P. K. / Jang, R. et al. | 2001
- 112
-
PDB2: Using Retrospective Claims Data to Design Clinical Safety Surveillance of Thiazolidinedione DrugsHenriques, C. / Schultz, D. / Milanette, T. / Todoroff, K. / Kim, M. et al. | 2001
- 112
-
PDB1: Diabetic Management Through Oral Glucose Lowering Agents: Treatment Pattern, Cost and Utilization AnalysisThompson, F. D. / Rosenblum, M. S. / O Neill, J. M. / Celebi, D. / Olmsted, E. et al. | 2001
- 113
-
PDB3: The Burden of Illness of Diabetes Mellitus Type 2 in Germany-A Pilot StudyTepe, M. / Kilburg, A. / Daniel, D. / Kirchhoff, D. / Rychlik, R. et al. | 2001
- 113
-
PDB4: Cost-Effectiveness and Cardiovascular Risk-An Analysis of Rosiglitazone Compared with other Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes MellitusOh, P. I. / Shane, L. G. et al. | 2001
- 114
-
PDB5: A Cost-Minimization Study to Determine the Impact of Adding Glucovance to a County Hospital FormularyLal, L. S. / Ogbonnaya, K. I. et al. | 2001
- 114
-
PDB6: An Early Look at TZD Use Among Type 2 Diabetes PatientsSchabert, V. F. / Guo, M. / Conklin, J. E. / Neslusan, C. A. et al. | 2001
- 114
-
PDB7: Costs and Effectiveness of Intensive Insulin Therapy for Type 2 DiabetesHisashige, A. / Katayama, T. / Mikasa, H. et al. | 2001
- 115
-
PDB9: Cost-Effectiveness Analysis of a Multidisciplinary Diabetes Care ClinicYokoyama, K. K. / Griffin, K. C. / Godley, P. J. / Cryar, A. K. / Woodward, B. W. et al. | 2001
- 115
-
PDB10: The Cost of New Onset Diabetes Mellitus Among US Renal Transplant RecipientsWoodward, R. S. / Schnitzler, M. A. / Lowell, J. A. / Haider, S. / Brennan, D. C. et al. | 2001
- 115
-
PDB8: Factors Associated with Prescription Claims for Blood Glucose Test Strips Among Fee-for-Service New Mexico Medicaid PatientsCordova, C. J. / Shah, B. M. / Dodd, M. A. / Gupchup, G. V. et al. | 2001
- 116
-
PDB11: Economic Outcomes of Diabetes Among an Employed PopulationLeong, S. A. / Summers, K. H. / Birnbaum, H. G. / Kemner, J. E. / Lentz, E. C. / Greenberg, P. E. et al. | 2001
- 116
-
PDB12: A Pharmacoeconomic Analysis of Weight-Reduction Therapy in a Hypothetical Cohort of Obese Chinese Patients with Impaired Glucose ToleranceLee, K. K. / You, J. H. / Ho, S. S. / Leung, W. Y. / Thomas, G. / Chan, T. Y. / Critchley, J. et al. | 2001
- 116
-
PDB13: Optimization of Diabetes Management in Germany Using a Computer Based Outcome Prognoses ModelBrandt, A. / Gozzoli, V. / Palmer, A. / Weiss, C. / Neeser, K. / Schramm, W. et al. | 2001
- 117
-
PDB14: Impact of a Diabetes Disease Management Program: A Retrospective Claims-Based EvaluationBerger, J. / Slezak, J. / O Leary, W. / McStay, P. / Johnson, K. / Addiego, J. et al. | 2001
- 117
-
PDB15: Does Patient Experience Matter? Type II Diabetes Patients' Stated Preferences for Insulin TherapiesSmith, G. / Bingham, M. / Johnson, F. R. / Bolinder, B. et al. | 2001
- 118
-
PDB16: An Overview of Pharmacoeconomics in Turkey: Cost Analysis and Reimbursement of Antidiabetic DrugsSapci, A. H. / Sapci, H. A. / Demirdamar, R. et al. | 2001
- 118
-
PEE2: The Cost-Effectiveness of Genetic Testing for Periodontal Disease. A Payer's PerspectiveHigashi, M. K. / Veenstra, D. / del Aguila, M. / Hujoel, P. et al. | 2001
- 118
-
PEE1: Antibiotic Prescribing Patterns for the Treatment of Initial Acute Otitis Media in Children Enrolled in Iowa Medicaid from 1990 Through 1997Park, T. R. / Brooks, J. M. et al. | 2001
- 119
-
PEE3: Dry-Eye Related Increases in Health Care Utilization and ExpendituresSmeeding, J. E. / McLaughlin, T. / Yazdani, C. / Walt, J. G. et al. | 2001
- 119
-
PEE5: Inappropriate Antibiotic Prescribing and Economic Outcomes for Pediatric Otitis MediaRahman, A. M. / Feldhaus, J. / Lawrence, L. / Rappaport, H. / Moser, E. et al. | 2001
- 119
-
PEE4: The French Version of the Psoriasis Disability IndexFinlay, A. / Corvest, M. / Lefrancois, P. / Taieb, C. et al. | 2001
- 120
-
PEE7: A Cost Comparison Study of Common Practice and Best Practice Treatment for Primary Open-Angle Glaucoma in the United StatesEvans, S. J. / Casciano, J. / Doyle, J. J. / Walt, J. G. et al. | 2001
- 120
-
PEE6: Cost-Effectiveness of Artificial Skin Substitute vs Allograft for Burn PatientsBron, M. S. / Hay, J. et al. | 2001
- 121
-
PGI2: Alternative Management Strategies for DyspepsiaWu, E. Q. / Hay, J. et al. | 2001
- 121
-
PEE8: Four Year Cost-Effectiveness of Initial Trabeculectomy Versus Conventional Therapy in Primary Open-Angle Glaucoma (POAG)Yu, E. / Hay, J. / Varma, R. / Globe, D. et al. | 2001
- 121
-
PGI1: Effects on Health Care Contacts and Days Absent from Work with Budesonide CIR Capsules in the Maintenance Treatment of Crohn's Disease in a US SettingEricsson, K. / Borg, S. et al. | 2001
- 122
-
PGI4: Health-Related Quality of Life (HRQoL) Data Reveal Differences Among Clinical "Responders"Watson, M. E. / Heath, A. T. / Northcutt, A. R. et al. | 2001
- 122
-
PGI3: A Prospective, Randomized Cost Analysis of Meperidine and Midazolam Versus Propofol for Complex Upper Endoscopy ProceduresShermock, K. M. / Vargo, J. J. / Zuccaro, G. / Maurer, W. G. et al. | 2001
- 123
-
PGI6: Cost-Effectiveness Analysis of Helicobacter pylori Eradication Triple Therapy Versus Conventional Therapy for Gastric and Duodenal Ulcers in JapanIkeda, S. / Tamamuro, T. / Asaka, M. et al. | 2001
- 123
-
PGI5: Health Care Cost Savings with Budesonide Controlled Ileal Release Capsules (CIR) in Crohn's DiseaseEricsson, K. / Lofberg, R. / Danielsson, A. / Floren, C. H. / Borg, S. et al. | 2001
- 123
-
PGI7: Budesonide CIR is Cost-Effective in Maintenance Therapy of Crohn's Disease in FinlandEricsson, K. / Karvonen, A. L. / Sintonen, H. / Borg, S. et al. | 2001
- 124
-
PGI9: Cost-Effectiveness of `Test&Treat' in Helicobacter pylori Infected Dyspeptic Patients in a Primary Care SettingChen, K. S. / Hay, J. et al. | 2001
- 124
-
PGI8: Rapid Impact of Rabeprazole on Symptom Distress Among Patients with Gastroesophageal Reflux DiseaseDamiano, A. / Adler, E. / Siddique, R. / Sloan, S. / Bhattacharjya, A. et al. | 2001
- 125
-
PGI10: Irritable Bowel Syndrome Costs Sickness Funds DM 2.8 Billion Per YearSchultes, H. J. / Guminski, W. / Rosche, U. / Ries, B. / Pirk, O. et al. | 2001
- 125
-
PGI11: Characterization and Markov Modeling of Gastroesophageal Reflux Disease States in a Large Health Care PlanBrelje, T. / Heaton, A. / Martin, S. / Bhattacharjya, A. / Dodd, S. / Thornhill, J. et al. | 2001
- 125
-
PGI12: Estimating Potential Utilization of Esomeprazole by Assessing GERD Symptom Control on Traditional PPI'sDeLattre, M. L. / Schaefer, M. / Morreale, A. P. / Plowman, B. K. et al. | 2001
- 126
-
PGI14: How Important is Appropriate Empirical Antibiotic Treatment for Intra-Abdominal Infections?Davey, P. / Libby, G. / Hunter, K. / Broomhall, J. / Kofteridis, D. / Steinke, D. / Taylor, E. / Yin, D. et al. | 2001
- 126
-
PGI13: Factors Associated with Physician Knowledge of Whether Prescription Drugs Are on FormularyShih, Y. C. / Sleath, B. et al. | 2001
- 127
-
PGI17: Comparison of Generic Versus Disease Specific Tools for the Measurement of Health-Related Quality of Life in Crohn's DiseaseWurtzbacher, J. D. / Gourley, G. K. / Reed, P. J. / Gourley, D. R. / Solomon, D. K. / Haas, J. W. et al. | 2001
- 127
-
PGI15: Computerized Assessment of Complications Following Colorectal SurgeryKroch, E. / Azimuddin, K. / Rosen, L. / Reed, J. F. et al. | 2001
- 127
-
PGI16: Analysis of the Long-Term Costs, Savings and Effects Generated by Infliximab to Normalize Quality of Life in Patients with Crohn's DiseaseAnnemans, L. / Moeremans, K. / Rutgeerts, P. / Lemmens, L. et al. | 2001
- 128
-
PID1: Efficacy of Zinc Lozenges on the Duration of Common Cold Symptoms: A Meta-Analysis RevisitedChaiyakunapruk, N. / Veenstra, D. L. / Sullivan, S. D. / Saint, S. / Bent, S. et al. | 2001
- 128
-
PID2: Impact of Cytomegalovirus (CMV)-Related Readmission on Post Heart Transplant Resource UseLeader, S. / Henderson, R. / Carlin, D. et al. | 2001
- 129
-
PID4: Economic Cost of HIV Infection in Untreated Workers: An Employer's PerspectiveChaikledkaew, U. / Liu, G. G. / Lyu, R. / Louie, S. et al. | 2001
- 129
-
PID3: Trends in Inpatient Costs for Acute Pancreatitis in the United StatesBell, C. F. / Stephens, J. M. / Botteman, M. F. / Pashos, C. L. / Ewing, M. et al. | 2001
- 129
-
PID5: Moxifloxacin vs Amoxicillin/Clavulanate in the Treatment of Acute Maxillary Sinusitis (AMS): Efficacy, Safety and Patient-Reported Outcomes in Primary CareRakkar, S. et al. | 2001
- 130
-
PID6: HIV/AIDS Health State Utilities Using Community and Patient Preference Weights: When Does It Matter?Schackman, B. R. / Goldie, S. J. / Freedberg, K. A. / Losina, E. / Brazier, J. / Weinstein, M. C. et al. | 2001
- 130
-
PID7: Observational Evaluation of Health State Utilities Among a Cohort of Sepsis PatientsDrabinski, A. / Williams, G. / Formica, C. et al. | 2001
- 131
-
PID10: Effects of Linezolid on Hospital Length of Stay in Methicillin-Resistant Staphylococcus Infections Estimated from Multivariate Survival AnalysisWillke, R. J. / Li, Z. J. / Glick, H. / Rittenhouse, B. E. / Hafkin, B. et al. | 2001
- 131
-
PID9: Cost-Effectiveness of Interferon Alfa Therapy for Chronic Hepatitis C with CirrhosisHisashige, A. / Katayama, T. / Mikasa, H. et al. | 2001
- 131
-
PID8: Costs of Health Care for Hepatitis C-Infected Members in a Managed Care Organization (MCO)Schaffer, M. / Phillips, A. L. / Mansukani, S. et al. | 2001
- 132
-
PID12: Averting Future AIDS Cases: Modeling Costs of Interventions with Out-of-Treatment Substance AbusersRichter, A. / Loomis, B. R. / Wechsberg, W. M. et al. | 2001
- 132
-
PID11: Pegylated (40KDa) Interferon Alfa-2a (PEGASYS®) Significantly Improves Tolerability, Quality of Life, and Work Productivity in Patients With Chronic Hepatitis CImperial, J. / Thuluvath, P. / Perrillo, R. P. / Rothstein, K. D. / Poulios, N. S. / Pappas, S. C. / Ackermann, S. P. / Doerschuk, B. S. et al. | 2001
- 133
-
PID14: Predictors of the Mental (MHS) and Physical Health Summary (PHS) Scores of the MOS-HIV in a Sample of HIV-Infected PatientsGriffis, D. L. / Delate, T. / Coons, S. J. et al. | 2001
- 133
-
PID15: Managing AIDS in the Era of Antiretroviral Therapy: Changes in the Rate and Cost of HospitalizationsO Brien, J. A. / Pierce, D. / Patrick, A. R. / Caro, J. J. et al. | 2001
- 133
-
PID13: Economic Evaluation of Rotavirus Vaccination for The NetherlandsWelte, R. / Jager, J. / van Duynhoven, Y. / de Wit, M. et al. | 2001
- 134
-
PID18: Methicillin-Resistant Staphylococcus Species Treatment Patterns in CanadaBecker, D. / Rosner, A. J. et al. | 2001
- 134
-
PID17: Economic Evaluation of Oseltamivir for Influenza Patients in JapanKobayashi, M. et al. | 2001
- 134
-
PID16: Cost Burden of Varicella-Zoster Virus Infection in a Managed Care SettingSchaffer, M. / Liu, M. / Scott, W. / Mansukani, S. et al. | 2001
- 135
-
PID20: Targeting Populations At-Risk for Urinary Tract Infection ComplicationDoyle, B. / Hess, G. et al. | 2001
- 135
-
PID19: An Economic Analysis of Cefdinir Versus Loracarbef for Treatment of Acute Exacerbations of Chronic BronchitisShah, S. N. / Smith, D. / Copley-Merriman, C. et al. | 2001
- 136
-
PID22: An Appraisal of Health-Related Quality of Life Instruments for Use in Patients Diagnosed with Human Immunodeficiency Virus (HIV) DiseaseJoshi, A. V. / Nau, D. P. / Kalsekar, I. D. et al. | 2001
- 136
-
PID23: Patterns of Antibiotic Use and Costs Associated with Episodes of Treatment for Common Outpatient Respiratory-Tract Infections: An Analysis of Managed-Care DataEdelman-Lewis, B. / Menzin, J. / Boulanger, L. / Leung, M. / Friedman, M. / Hurley, J. S. / Harnett, J. / Wilson, J. et al. | 2001
- 136
-
PID21: The Cost-Effectiveness Analysis of Lamivudine in the Treatment of Chronic Hepatitis B in PolandOrlewska, E. et al. | 2001
- 137
-
PID25: Economic Evaluation of Macrolides and Fluoroquinolones for the Treatment of Respiratory Tract InfectionsLachaine, J. / Laurier, C. / Manzi, P. et al. | 2001
- 137
-
PID24: Cost Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Community-Acquired Pneumonia in an Outpatient PopulationBell, T. J. / Loomis, B. R. / Mauskopf, J. A. / L Italien, G. J. / Gallagher, K. M. et al. | 2001
- 138
-
PID26: Pharmacoeconomic Evaluation of Cefuroxime in Abdominal HysterectomyKarpov, O. / Zaytsev, A. et al. | 2001
- 138
-
PID27: Does a Day Still Make a Difference? A Decision Analysis of Adult Streptococcal PharyngitisRousculp, M. D. et al. | 2001
- 138
-
PID28: Comparing Differences in Clinical Effectiveness, Nephrotoxicity, and Cost-Effectiveness of Aminoglycoside Therapy Between Alternative Dosing ProtocolsReynolds, R. / Gupchup, G. / Borrego, M. / Raisch, D. / Netravali, S. et al. | 2001
- 139
-
PMH1: Should the 51 Items of the Schizophrenia Outcomes Assessment Project (SOAP-51) Be Weighted?Barr, J. / Schumacher, G. / Mason, E. / Ohman, S. / Goren, J. / Hanson, A. et al. | 2001
- 139
-
PMH2: Treatment Course and Charges for Depressed Patients Treated with Sertraline, Venlafaxine, and Venlafaxine XR in the Managed Care SettingHirschfeld, R. / Eaddy, M. / Grudzinski, A. et al. | 2001
- 140
-
PMH5: From First to Second: Impact of Participant Characteristics on the Time to First Switch in a Schizophrenia PopulationRusso, P. / Vasey, J. et al. | 2001
- 140
-
PMH4: Assessment of Patients' Attitudes Toward Antipsychotic Treatment in a 40-Week Randomized, Controlled TrialDugar, A. / Stuelpner, J. E. / Mackell, J. A. / Miceli, R. J. et al. | 2001
- 140
-
PMH3: Is Depression the Major Cause of Impaired Quality of Life in Schizophrenic Patients?Toumi, M. / Pettersson, A. / Llorca, P. M. / Lancon, C. / Aballea, S. et al. | 2001
- 141
-
PMH6: Change in Instrumental Activities of Daily Living Associated with Antidepressants in Older Depressed PatientsEdell, W. S. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Adams, B. E. / Jensik, S. E. et al. | 2001
- 141
-
PMH7: Change in Maladaptive Behaviors Associated with Antidepressants in Older Depressed PatientsJensik, S. E. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Edell, W. S. / Adams, B. E. et al. | 2001
- 142
-
PMH8: Impact of Current Antidepressants on Cognition in Older Patients with DepressionAdams, B. E. / Mayo, K. W. / Sandoval, R. I. / Bailey, K. L. / Jensik, S. E. / Edell, W. S. et al. | 2001
- 142
-
PMH9: Health Care Utilization and Costs in Schizophrenic Patients Taking Risperidone Versus Olanzapine in a Veterans Administration PopulationShermock, K. M. / Fuller, M. A. / Secic, M. / Laich, J. S. / Durkin, M. B. et al. | 2001
- 142
-
PMH10: Health Outcomes of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Health Care Use and Work Status of CaregiversNoe, L. / Hankin, C. S. et al. | 2001
- 143
-
PMH11: Schizophrenia Care and Assessment Program (SCAP): The Impact of Clinical Syndrome, Antipsychotic Medication Treatment and Adherence on Outpatient Psychiatric UtilizationRusso, P. / Smith, M. et al. | 2001
- 143
-
PMH12: Prevalence of Comorbid Anxiety and Depression Among Patients Prescribed SSRI MonotherapyGrotzinger, K. M. / Chang, L. L. et al. | 2001
- 144
-
PMH15: A Retrospective Economic Evaluation of Olanzapine Versus Risperidone in the Treatment of SchizophreniaZhao, Z. et al. | 2001
- 144
-
PMH14: Deficit Syndrome and Drug Use Patterns in a Community-Based Schizophrenia CareRusso, P. / Kirkpatrick, B. et al. | 2001
- 144
-
PMH13: Pre-Treatment Patient Differences: Choice of Drug Therapy Within SchizophreniaGibson, P. J. / Loosbrock, D. L. et al. | 2001
- 145
-
PMH16: Use of Rasch Models for Validation of Instruments Used in Mental Health EvaluationLancon, C. / Toumi, M. / Pettersson, A. / Aballea, S. / Fournier, A. et al. | 2001
- 145
-
PMH17: Typical and Atypical Antipsychotics in the Treatment of Schizophrenia: Assessment of Clinical And Economic Outcomes Using a Markov ModelNeeser, K. / Schramm, W. / Brandt, A. / Hoffler, J. / Jurgens, T. / Mast, O. et al. | 2001
- 146
-
PMH19: Risk of Hospitalization for Patients with Bipolar DisorderLing, D. C. / Bresnahan, B. W. / White, A. S. / Neslusan, C. A. / Crown, W. H. et al. | 2001
- 146
-
PMH18: Health Care Utilization in Patients with Treatment Resistant DepressionCrown, W. H. / Ling, D. C. / Finkelstein, S. N. / Berndt, E. R. / White, A. S. et al. | 2001
- 146
-
PMH20: Dosing of Benzodiazepine Hypnotics in Elderly PatientsYoung, J. K. / Schultz, D. / Foster, D. / Heller, S. et al. | 2001
- 147
-
PMH21: Quality of Life of Non-Institutional Caregivers of Schizophrenic Patients: Contribution of Qualitative Interviews to Questionnaire GenerationAuquier, P. / Simeoni, M. C. / Azorin, J. M. / Lancon, C. / Toumi, M. et al. | 2001
- 147
-
PMH22: Patterns of Antidepressant Use and Health Care Costs in Depressed Patients Who Received SSRI TherapyWade, S. W. / Berzon, R. / Patton, M. P. / Koch, P. / Batra, D. et al. | 2001
- 148
-
PMH23: Deinstitutionalization of Schizophrenic Patients: Cost-Consequences and Policy Implication of Intensive Case Management Versus Standard Case ManagementLlorca, P. M. / Toumi, M. / Hansen, K. / Barre, S. / Francois, C. et al. | 2001
- 148
-
PMH25: A Model Comparing Olanzapine and Ziprasidone in Patients with SchizophreniaAlexeyeva, I. / Mauskopf, J. / Earnshaw, S. / Gibson, P. J. / Ascher-Svanum, H. / Ramsey, J. L. et al. | 2001
- 148
-
PMH24: The Cost of Acute Hospitalization for Anorexia Nervosa and BulimiaO Brien, J. A. / Patrick, A. R. et al. | 2001
- 149
-
PMH28: Depression and Homelessness, a French InitiativeEmmanuelli, X. / Hassin, J. / Smadja, C. / Taieb, C. et al. | 2001
- 149
-
PMH27: Cost-Utility Analysis of Quetiapine Compared to Risperidone in the Treatment of Patients with Schizophrenia or Other Psychotic DisordersSimons, W. R. / Meddis, D. et al. | 2001
- 149
-
PMH26: Outpatient Antipsychotic Use: Comparing Atypical and Conventional Antipsychotic Adherence Using a National Retail Pharmacy Data BaseVanelli, M. R. et al. | 2001
- 150
-
PMH30: Differences in Health Care Expenditures Among Patients Treated for Depression with or without AnxietyCrown, W. / Wan, G. J. / Berndt, E. R. / Finkelstein, S. N. / Ling, D. et al. | 2001
- 150
-
PMH29: Cost Analysis of Olanzapine Versus Risperidone in the Treatment of Uncontrolled SchizophreniaZhao, Z. et al. | 2001
- 151
-
PMH31: Pharmacoeconomic Evaluation of the Treatment with Olanzapine in "Revolving Door" Schizophrenic PatientsGurovich, I. / Lyubov, E. / Shmukler, A. et al. | 2001
- 151
-
PMH32: Barriers to the Use of Medications to Treat AlcoholismMark, T. L. / Kranzler, H. R. / Poole, V. H. / Hagen, C. A. / McLeod, C. / Crosse, S. E. et al. | 2001
- 151
-
PMH33: Olanzapine Versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs Among Texas Medicaid PatientsRascati, K. L. / Johnsrud, M. / Crismon, M. L. / Barber, B. L. / Lage, M. J. et al. | 2001
- 152
-
PMH34: Switching and Augmentation of Antidepressants in Older Depressed PatientsAdams, B. E. / Jensik, S. E. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Edell, W. S. et al. | 2001
- 152
-
PMH35: Patterns of Antidepressant and Antipsychotic Medication Use in Medicaid, 1995-1999Gregorian, R. / Gemmen, E. et al. | 2001
- 153
-
PMH36: Dosing of Benzodiazepine Hypnotics in Elderly PatientsYoung, J. K. / Schultz, D. / Foster, D. / Heller, S. et al. | 2001
- 153
-
PPN2: Use of Galantamine in The Netherlands for the Treatment of Mild to Moderate Alzheimer's DiseaseCard, J. / Salas, M. / Getsios, D. / Mehnert, A. / AHEAD Study Group et al. | 2001
- 153
-
PPN1: An Internet Study of WTP for Migraine PharmacotherapiesLenert, L. A. / Minh, C. / Jackson, C. et al. | 2001
- 154
-
PPN4: Utility Assessments of Opioid Treatment in the US, Canada and Australia for Patients with Chronic Non-Malignant PainSchmier, J. / Palmer, C. / Ingham, M. / Mathur, S. / Dodd, S. / Gourlay, G. et al. | 2001
- 154
-
PPN3: The Impact of Dementia on Caregiver Quality of LifeGold, K. F. / Botteman, M. F. / Kemp, R. / Kittner, B. / Pashos, C. L. et al. | 2001
- 155
-
PPN6: Validation of the 24 Hour Headache Disability Questionnaire (DISQ-24) in a Sample of Headache SufferersRunken, M. C. / Kwong, W. / Davis, K. / Batenhorst, A. et al. | 2001
- 155
-
PPN5: Comparison of Costs and Cost-Effectiveness of Oxcarbazepine and Sodium Valproate for New/Recent Onset Partial SeizuresBazalo, G. / Sachdeo, R. / Graham, S. / Chang, S. / Cohen, A. et al. | 2001
- 155
-
PPN7: A Model for Predicting the Incidence of Migraine in the Idaho Medicaid PopulationShaw, J. / Joish, V. / Cady, P. S. et al. | 2001
- 156
-
PPN8: Psychometric Evaluation of Widely Used Pain Measures for Purpose of Computerized Dynamic Pain AssessmentZhao, J. H. / Ware, J. E. / Kosinski, M. / Bjorner, J. B. / Turner-Bowker, D. et al. | 2001
- 156
-
PPN9: How is Pain Felt Across Countries? The Short-Form McGill Pain Questionnaire (SF-MPQ) in 10 LanguagesConway, K. / Uzun, V. / Alacoque, J. / Abetz, L. / Melzack, R. / Plante, M. et al. | 2001
- 157
-
PPN11: The Migraine in France in 2000: Epidemiological DataHenry, P. / Auray, J. P. / Duru, G. / Chazot, G. / Dartigues, J. F. / Lanteri-Minet, M. / Lucas, C. / Pradalier, A. / El Hasnaoui, A. / Gaudin, A. F. et al. | 2001
- 157
-
PPN12: Differences in Health-Related Quality of Life Between Migraineurs with and without Prophylactic Medication UseGirts, T. K. / Lofland, J. H. / O Connor, J. P. et al. | 2001
- 157
-
PPN10: Survival and Nursing Home Free Survival (NHFS) of AD PatientsWu, E. Q. / Hay, J. et al. | 2001
- 158
-
PPN13: Delays in Nursing Home Placement for Patients with Alzheimer's Disease Associated with Treatment with Donepezil May Have Health Care Cost-Saving ImplicationsProvenzano, G. / Duttagupta, S. / McRae, T. / Mastey, V. / Ellis, B. / Ieni, J. et al. | 2001
- 158
-
PPN14: A Prognostic Model to Predict Quality of Life Chances After Subarachnoid HemorrhageToth, K. / Szende, A. / Contreraz, M. / Machovich, A. / Futo, J. / Nyari, I. et al. | 2001
- 159
-
PPN17: Addressing Paradoxes in Economic Evaluations (EES). An Example Using Motor Neuron Disease (MND)Bose, U. K. / Burrell, A. / Ward, J. et al. | 2001
- 159
-
PPN15: Multiple Pain Relief Assessment in Women Undergoing Natural Versus Epidural Delivery with Ropivacain or BupivacainSzende, A. / Kincses, Z. S. / Zimanyi, M. / Kadar, Z. / Zorenyi, G. et al. | 2001
- 159
-
PPN16: Economic Burden and Loss in Quality of Life Due to Low Back PainSzende, A. / Lovas, K. / Szebenyi, B. / Balint, G. / Hejj, G. et al. | 2001
- 160
-
PPN20: Estimated Resource Use and Cost of Mitoxantrone vs Placebo in Patients with Progressive-Relapsing and Secondary-Progressive Multiple Sclerosis: Results from the MIMS TrialDurgin, T. L. / Wanke, L. A. / Goodkin, D. / Ghalie, R. et al. | 2001
- 160
-
PPN19: Comparison of HUI2 and HUI3 Scores for Patients with Alzheimer's DiseaseNiwata, S. / Yamada, Y. / Ikeda, S. / Ikegami, N. et al. | 2001
- 160
-
PPN18: Cost Savings in Migraine Associated with Less Chest Pain on New Triptan TherapyWang, J. T. / Barr, C. E. / Torigoe, Y. / Wang, E. I. / Rowland, C. R. / Goldfarb, S. D. et al. | 2001
- 170
-
PHP6: Activities, Functions and Structure of Pharmacy and Therapeutics Committees in Israeli HospitalsRotem, R. / Reuveni, H. / Goldberg, A. et al. | 2001
- 170
-
PHP7: Application of Health Economics in the Canadian Pharmaceutical IndustryHirji, Z. / Rindress, D. E. / Welner, S. A. et al. | 2001
- 170
-
PHP5: Polish Guidelines for Conducting Pharmacoeconomic Evaluations in Comparison to International Health Economic GuidelinesOrlewska, E. / Mierzejewski, P. et al. | 2001
- 171
-
PHP10: The Potential Benefits and Drawbacks of Allowing Direct-to-Consumer Advertising of Pharmaceuticals in EuropeDickson, A. J. et al. | 2001
- 171
-
PHP9: Comparison of Technology Assessment in Large Medical Groups and Health Maintenance Organizations (HMOS)Wise, S. / Donohue, T. F. et al. | 2001
- 171
-
PHP8: Practice Use of Pharmacoeconomics Data in Hospital Formulary DecisionsOdedina, F. T. / Sullivan, J. L. / Nash, R. / Clemmons, C. D. et al. | 2001
- 172
-
PHP12: Acute Care Elderly Units: Their Prevalence, Characteristics and DeterminantsJayadevappa, R. / Raziano, D. B. / Samakur, M. / Lavizzo-Mourey, R. et al. | 2001
- 172
-
PHP11: Use of the Andersen Health Care Services Utilization Behavioral Model to Understand the Relationship Between Health Insurance Coverage and Health Care Services Utilization Among the ElderlyYang, M. / Barner, J. C. et al. | 2001
- 173
-
PHP13: Indices for Evaluation of Drug Cost/Utilization: Every Silver Lining Has a Gray CloudValuck, R. J. et al. | 2001
- 173
-
PHP14: Cost Analysis of Pharmaceutical Services in a Teaching InstitutionBussieres, J. F. / Lebel, D. et al. | 2001
- 174
-
PHP15: A Survey of Public Hospital Pharmacists in Singapore on Their Views About the `Formulary' and Its Decision-Making ProcessRoy, A. / Li, S. C. et al. | 2001
- 174
-
PHP16: The Value of Various Forms of Evidence in Drug Formulary Decision MakingMorris, L. / Aikin, K. et al. | 2001
- 174
-
PHP17: Patient Outcomes in the Sedated ICU PatientKamath, T. / Hopefl, A. / Chaikledkaew, U. / Johnson, K. A. et al. | 2001
- 175
-
PHP18: A Model for Comparing Costs Associated with Prescription Wastage with Application to VA Prescription DataWalton, S. M. / Johnson, N. E. / Arondekar, B. V. / Schumock, G. T. et al. | 2001
- 175
-
PHP20: The Lag Between Effectiveness and Cost-Effectiveness Evidence of New Drugs and Decision-Making in Health CareStoykova, B. A. / Drummond, M. / Kleijnen, J. et al. | 2001
- 175
-
PHP19: Using Financial Ratios to Compare Pharmacy Spending in the Department of Veterans AffiarsSampson, J. M. et al. | 2001
- 176
-
PHP22: Patient Adherence to Drug Therapy in a Three-Tier Copayment StructureHutchison, S. et al. | 2001
- 176
-
PHP21: Single European-Level Cost-Effectiveness Analysis: Over the Fourth Hurdle and into the Ditch?Hutton, J. / Nuijten, M. / Chambers, M. et al. | 2001
- 176
-
PHP23: Drug Reimbursement Program for Indigent Patients: An Economic Impact on the Hospital Administration BudgetNguyen, A. B. / Arbuckle, R. / Anderson, R. W. / Sansgiry, S. S. et al. | 2001
- 177
-
PQP2: Role of Health-Related Quality of Life Outcomes in the European Drug Regulatory Process: A Review of the EMEA DocumentsAcquadro, C. / Staniek, V. / ERIQA Group et al. | 2001
- 177
-
PQP1: Lessons Learned from Developing a Psychometrically Based Sedation Questionnaire in Pharmacologically Paralyzed Critically Ill PatientsKane, S. L. / Dasta, J. F. / Pathak, D. S. et al. | 2001
- 178
-
PQP4: Cross-Cultural Variations in SF-12 Scores Among Individuals with Various Health ConditionsBolge, S. C. / Eschmann, B. / Donohue, J. A. et al. | 2001
- 178
-
PQP3: Defining Clinically Meaningful Change in Health-Related Quality of LifeCrosby, R. D. / Kolotkin, R. L. / Williams, G. R. et al. | 2001
- 178
-
PQP5: Translating SF-36 Scores into Preferences: An Examination of the Performance of Two Predictive EquationsMeletiche, D. M. / Roberts, C. S. / Lofland, J. H. et al. | 2001
- 179
-
PQP7: Is Compliance with Drug Treatment Correlated with Health Related Quality of Life?Cote, I. / Farris, K. B. / Feeny, D. H. et al. | 2001
- 179
-
PQP6: Health Utilities Index Mark 3: Agreement Between Raters and Between Modalities of AdministrationVerrips, G. / den Ouden, A. / Bonsel, G. / Gemke, R. / Paneth, N. / Verloove-Vanhorick, S. et al. | 2001
- 179
-
PQP8: Evaluating Bias Introduced by Annualizing Utilization and Cost MeasuresZodet, M. / de Lissovoy, G. et al. | 2001
- 180
-
PQP10: Negative Affectivity: A Significant Contaminant of Patient Reported Health Related Quality of Life Instruments (SF-36)Reed, P. J. / Moore, D. D. et al. | 2001
- 180
-
PQP9: Quality of Life Patients with Fabry DiseaseBotteman, M. F. / Pastores, G. M. / Gold, K. F. / Yeh, J. / Ali, J. / Aliski, W. / Pashos, C. L. et al. | 2001
- 181
-
PQP11: The Health and Work Questionnaire (HWQ): An Instrument for Assessing Workplace Productivity in Relation to Worker HealthShikiar, R. / Rentz, A. M. / Halpern, M. T. / Khan, Z. M. et al. | 2001
- 181
-
PMA1: Methodological Advances in the Assessment of Quality of Life in Clinical TrialsHufford, M. R. et al. | 2001
- 182
-
PMA2: Development of Cost-Effective Web-Based Outcomes Research Studies and Disease Management ProgramsAmbegaonkar, A. J. / Day, D. et al. | 2001
- 182
-
PMA4: An Economic Proof and Application That Formulary Restrictions Within Drug Classes Always Result in Higher CostsSimons, W. R. et al. | 2001
- 182
-
PMA3: Does Where You Life Affect If and How You Discount Future Costs and Benefits in Economic Evaluation? Should It?Faulkner, L. A. / Gafni, A. / O Brien, B. J. et al. | 2001
- 183
-
PMA6: The Reduction of Sample Size for a Cost-Effectiveness Trial Using a New Method: The Eight Cases in JapanKamae, I. / Yanagisawa, S. et al. | 2001
- 183
-
PMA5: A Risk Adjustment Methodology for Claims DataWilson, P. / Yuan, Y. / Dowse, B. T. et al. | 2001
- 183
-
PMA7: Controlling for Biases from Measurement Errors in Health Outcomes Research Using Structural Equation ModelingShi, J. / McCombs, J. / Hay, J. / Nichol, M. / Chou, C. P. / Hsiao, C. et al. | 2001
- 184
-
PMA8: Development of a Chronic Disease Indicator Using a Managed Care PopulationMalone, D. C. / Raebel, M. A. et al. | 2001
- 184
-
PMA9: Bayesian or Classical Design and Analysis: Does It Make a Difference?Bloom, B. S. et al. | 2001
- 185
-
PMA11: Comparison of Statistical Tests for the Cost/Effectiveness RatiosKim, S. / Moeschberger, M. / Pathak, D. et al. | 2001
- 185
-
PMA12: Relationship Between Nonparametric Receiver Operating Characteristic Analysis and a Likelihood-Ratio test for Model Selection: 1. A Monte Carlo Simulation Using Continuous DataShaw, J. W. / Horrace, W. / Coons, S. J. et al. | 2001
- 185
-
PMA10: Description of Cost/Effectiveness Ratio DistributionsKim, S. / Moeschberger, M. / Pathak, D. et al. | 2001
- 186
-
PMA14: Bayesian Decision Analysis in Outcome Studies with Small Numbers of Events: A Simulation Based Prediction ApproachWang, J. / Davey, P. / MacDonald, T. et al. | 2001
- 186
-
PMA13: Relationship Between Nonparametric Receiver Operating Characteristic Analysis and a Likelihood-Ratio Test for Model Selection: II. A Monte Carlo Simulation Using Discrete DataShaw, J. W. / Shahriar, J. / Horrace, W. et al. | 2001
- 187
-
PMA17: The European Service Mapping Schedule (ESMS): A New Instrument for Mental Health Services Research, Results of a French StudyAzorin, J. M. / Goudemand, M. / Toumi, M. / Johnson, S. / Pettersson, A. et al. | 2001
- 187
-
PMA15: Conducting Pharmacoeconomic Research in the Absence of Country-Specific DataMiller, B. / Rosner, A. J. / Becker, D. L. et al. | 2001
- 187
-
PMA16: Confirmation of the Decision Rules and Assumptions for a Model of Diabetes Treatment Using an Expert PanelCaro, J. / Salas, M. / Ward, A. / Sung, J. / Shah, A. et al. | 2001
- 188
-
WW1: Methodological Complexities in Using Administrative Claims Databases to Evaluate Quality of Care for Attention-Deficit/Hyperactivity DisorderHankin, C. S. / Wright, A. T. et al. | 2001
- 188
-
PMA18: The Avandia Worldwide Awareness Registry (AWARE®): An Internet-Based Program for Evaluation of Clinical, Humanistic and Economic Outcomes of Patients with Type 2 DiabetesBakst, A. / Meletiche, D. M. / Arnold, R. / Harjono, H. / Najib, M. / Cobitz, A. et al. | 2001
- 189
-
WW2: Using Linkable Clinical and Administrative Claims Data to Improve Outcomes Research: Selected Case Studies from Oncology and Diabetes MellitusMenzin, J. / Lang, K. et al. | 2001
- 189
-
WW4: A New Approach to Disease Modeling with Numerous Comparators and Multiple Decision TreesBecker, R. / Noe, L. / Gore, M. / Martino, S. et al. | 2001
- 189
-
WW3: Issues and Problems Encountered in Models on Prevention of Deep Venous Thrombosis (DVT)Annemans, L. / Lamotte, M. / Huybrechts, M. et al. | 2001
- 190
-
WW6: Conducting Cost-Benefit and Cost-Utility Analysis: A Conjoint Analysis ApproachHauber, A. B. / Bala, M. V. / Fehnel, S. E. et al. | 2001
- 190
-
WW5: Creative Approaches to Modeling Life Expectancy Gains for Economic Evaluation Using Published DataWeinstein, M. C. / Appadoo, S. et al. | 2001
- 191
-
WW7: Beyond Cost-Effectiveness: The Strategic Value of Productivity-Related Outcomes in Clinical Trials, Burden of Illness Studies, and Post-Marketing ResearchOzminkowski, R. J. / Goetzel, R. Z. / Crown, W. C. / Long, S. R. / Ling, D. et al. | 2001
- 191
-
WW8: Constructing Episodes of Care from Claims Data: Applications to Pharmacoeconomic and Outcomes ResearchHuse, D. / Portnoy, M. et al. | 2001
- 192
-
WW11: Using Markov Decision Models to Develop Optimal Treatment Pathways: An IllustrationBala, M. V. / Mauskopf, J. A. et al. | 2001
- 192
-
WW10: Multinational Economic Studies: Lessons Learned from Trial-Based and Modelling StudiesDrummond, M. F. / Grima, D. et al. | 2001
- 192
-
WW9: The Use of Multi-Attribute Analysis and Pair-Wise Comparisons for Group Decision-MakingHess, G. P. / Forman, E. et al. | 2001
- 193
-
WW14: Making Models BetterMatchar, D. B. / Samsa, G. P. / Parmigiani, G. et al. | 2001
- 193
-
WW13: Challenges in Performing Meta Analysis in Heart Failure Outcomes ResearchMullins, C. D. / Weiss, S. / Fulda, T. et al. | 2001
- 193
-
WW12: Use of Medication Compliance Data in Outcome AnalysesCramer, J. A. / Urquhart, J. et al. | 2001
- 194
-
WW16: Patient Registries: Their Value in Outcomes ResearchRussell, M. W. et al. | 2001
- 194
-
WW15: Identifying the Impact of a Treatment on Outcomes and Costs Using Observational Data: Overcoming Selection BiasPolsky, D. / Glick, H. A. et al. | 2001
- 195
-
WW17: Selecting Health-Related Quality-of-Life Measures: First PrinciplesErickson, P. et al. | 2001
- 195
-
WW18: The Role of Health State Experience in Longitudinal Conjoint Analysis of Patient PreferencesBingham, M. / Smith, G. et al. | 2001